Abrinica, Clyde .
HRN: 27-22-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2025
CIPROFLOXACIN 500MG (TAB)
11/03/2025
11/10/2025
NGT
80mg/pptab
Q12
Pseudomonas Aeroginosa Infection
Checking Final Appropriateness
Indication: Culture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes